Information in consent form in Biomedical Research that research Participants would Like to Know.
- Conditions
- None, study is to understand what information is relevant to participants in the informed consent process.
- Registration Number
- CTRI/2017/07/009043
- Lead Sponsor
- Study funded by ICMR in India Internationally coordinated by FERCAP without financial support
- Brief Summary
The study is multicentre, questionnaire based survey which would besimultaneously carried out in 10 member countries of Forum for Ethical ReviewCommittees in the Asian and Western Pacific region (FERCAP). ICMR BioethicsUnit, NCDIR, Bangalore has been identified to be the Country Coordinator for thesurvey at four sites in India. Data will be collected through an anonymous,self-administered, structured, paper-based questionnaire. The questionnaireregarding the contents of ICF would be given to the research participants toanswer the questions. The study results may provide important insights aboutthe contents of the ICF which would be beneficial to both Investigators andEthics Committees. The data obtained from the survey will be analyzed at theNational and International level (FERCAP member countries) which would help usto develop standard format for ICF across the country as well as in South EastAsia Region.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- All
- Target Recruitment
- 3000
The target populations are individuals participating in any ongoing biomedical research at study sites.
Individuals who refuse to answer the questionnaire for any reason or have communication difficulties due to language problems or cognitive disabilities will be excluded.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method national level (in each country), and June to November 2017 Results may provide important insights about the Informed Consent Form that will guide June to November 2017 The outcomes will be beneficial to investigators and EC members at three levels: June to November 2017 regional level (in the FERCAP region). June to November 2017 iThe investigators to develop better and suitable ICFs for their biomedical research studies. June to November 2017 iiThe ethics committee members when they assess ICFs during the ethical review and approval process. June to November 2017 local level (at each particular study site), June to November 2017
- Secondary Outcome Measures
Name Time Method The study could provide solutions to address the challenges to determine the extent of adequate information required in biomedical research conducted at different settings involving various groups of populations. It would also help understand the requirement of informed consent in India and to compare them with those in other countries of the South East Asia Region. Information received would also help us in refining the informed consent requirements as the results may have policy implications June to November 2017
Trial Locations
- Locations (5)
National Centre for Disease Informatics and Research (NCDIR)
🇮🇳Rural, KARNATAKA, India
National Institute for Research in Reproductive Health (NIRRH)
🇮🇳Mumbai, MAHARASHTRA, India
National Institute for Research in Tuberculosis (NIRT)
🇮🇳Madurai, TAMIL NADU, India
National Institute of Cholera & Enteric Diseases (NICED)
🇮🇳Kolkata, WEST BENGAL, India
Sanjay Gandhi Post Graduate Institute of Medical Sciences (SGPGI)
🇮🇳Lucknow, UTTAR PRADESH, India
National Centre for Disease Informatics and Research (NCDIR)🇮🇳Rural, KARNATAKA, IndiaDr Roli Mathur Country CoordinatorPrincipal investigator80-22176301icmr.bioethics@gmail.com